KRT20 and breast cancer: This cytokeratin is reported as a primitive stem cell marker precursor to KRT5 and KRT20 in urothelial differentiation and has been the basis for differentiation risk stratification of BC patients, being consistently associated with tumor recurrence and poor overall survival, independent of established and clinical pathological variables [35, 36].